Abstract

Fetal growth restriction (FGR), followed by postnatal early catch-up growth, is associated with an increased risk of metabolic dysfunction, including type 2 diabetes in humans. This study aims to determine the effects of FGR and early catch-up growth after birth on the pathogenesis of type 2 diabetes, with particular attention to glucose tolerance, pancreatic islet morphology, and fibrosis, and to elucidate its mechanism using proteomics analysis. The FGR rat model was made by inducing mild intrauterine hypoperfusion using ameroid constrictors (ACs). On day 17 of pregnancy, ACs were affixed to the uterine and ovarian arteries bilaterally, causing a 20.9% reduction in birth weight compared to sham pups. On postnatal day 4 (P4), the pups were assigned to either the good nutrition (GN) groups with 5 pups per dam to ensure postnatal catch-up growth or poor nutrition groups with 15 pups per dam to maintain lower body weight. After weaning, all pups were fed regular chow food ad libitum (P21). Rats in both FGR groups developed glucose intolerance; however, male rats in the FGR good nutrition (FGR-GN) group also developed hypertriglyceridemia and dysmorphic pancreatic islets with fibrosis. A comprehensive and functional analysis of proteins expressed in the pancreas showed that FGR, followed by early catch-up growth, severely aggravated cell adhesion-related protein expression in male offspring. Thus, FGR and early catch-up growth caused pancreatic islet morphological abnormalities and fibrosis associated with the disturbance of cell adhesion-related protein expressions. These changes likely induce glucose intolerance and dyslipidemia in male rats.

Details

Title
Fetal growth restriction followed by early catch-up growth impairs pancreatic islet morphology in male rats
Author
Jabary, Mahboba 1 ; Onoda, Atsuto 2 ; Kitase, Yuma 3 ; Ueda, Kazuto 3 ; Mimatsu, Haruka 3 ; Go, Shoji 3 ; Miura, Ryosuke 3 ; Tsuji, Masahiro 4 ; Takahashi, Yoshiyuki 5 ; Hayakawa, Masahiro 3 ; Sato, Yoshiaki 3 

 Nagoya University Hospital, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya, Japan (GRID:grid.437848.4) (ISNI:0000 0004 0569 8970); Nagoya University Graduate School of Medicine, Department of Pediatrics, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
 Nagoya University Hospital, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya, Japan (GRID:grid.437848.4) (ISNI:0000 0004 0569 8970); Sanyo-Onoda City University, Department of Toxicology and Health Science, Faculty of Pharmaceutical Sciences, Sanyoonoda, Japan (GRID:grid.469470.8) (ISNI:0000 0004 0617 5071) 
 Nagoya University Hospital, Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya, Japan (GRID:grid.437848.4) (ISNI:0000 0004 0569 8970) 
 Kyoto Women’s University, Department of Food and Nutrition, Kyoto, Japan (GRID:grid.411223.7) (ISNI:0000 0001 0666 1238) 
 Nagoya University Graduate School of Medicine, Department of Pediatrics, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X) 
Pages
2732
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2776897721
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.